SHREECEMBSESHREE CEMENT LIMITED· Cement & Cement ProductsHighNeutral
Announced Fri, 31 Jul, 2026 · 14:23 IST

Shree Cement Q1 FY26-27: Revenue Up 14%, PAT Down 29% YoY

Ebitda Margin CompressionResults View source PDFExplain this filing

SHREECEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹26510.00
prior close
₹26060.00
announcement price
In-mkt
timing
Nifty 100market+0.5%-1.9% vs market
Cement & Cement Products peers, median of 35sector-0.1%-1.4% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty 100 and 1.4 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.3
10m
-0.9
15m
-0.7
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5+0.5-1.9-0.1-1.4
Next day
+1.2+2.0-0.9+0.8+0.3
2d
+1.5+1.4+0.1+0.5+1.0
3d
+1.5+1.5-0.0+1.7-0.3
4d
-1.0+1.5-2.5+1.1-2.1
5d
-1.6+1.4-2.9+0.8-2.4
1w
-3.8+1.0-4.8+0.6-4.4
15d
-8.4+0.1-8.5-1.1-7.3
1m
-12.5-0.5-12.0-2.8-9.7
2m
-15.7-6.4-9.3-7.2-8.6
3m
—————
UpDownMarket · Nifty 100Sector · Cement & Cement Products peers, median of 35Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Cement Q1 FY26-27 standalone: Revenue from Operations up 13.6% YoY at Rs 5,622.68 crore, but PAT fell 29.2% to Rs 437.99 crore and EBITDA declined 10.8% to Rs 1,275.85 crore. Operating margin compressed sharply from 29% to 23% YoY on higher power, fuel and freight costs. Consolidated revenue rose 18% to Rs 6,233.13 crore; consolidated PAT fell 17.5% to Rs 531.12 crore. EPS stood at Rs 121.39 versus Rs 171.42 a year ago. Auditor issued an unqualified limited review report.

Likely market impact

Weak margins despite revenue growth. Sharp 29% YoY PAT fall signals cost pressure. Likely negative for stock in near term.